PINK:NMLSF

Nova Mentis Life Science Stock Predictions

Healthcare > Biotechnology

Buy NMLSF

*Your capital is at risk

$0.0491

-0.0718 (-59.37%)

At Close: Jun 22, 2026

Currently predicting for Wed, 24 Jun 2026

NMLSF Live board

Community Bull/Bear

Target Next close

Join the NMLSF prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

NMLSF Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For NMLSF

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

NMLSF Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT NOVA MENTIS LIFE SCIENCE CORP.

Nova Mentis Life Science Corp., through its subsidiaries, engages in the research and development of medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder in Canada. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes; and development of cannabis products. Nova Mentis Life Science Corp. has a research agreement with the Univ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
IDYA $28.98	18.12%	Jun 12
DHI $146.71	6.29%	Jun 10
PHM $118.49	6.02%	Jun 10
EAT $140.46	17.09%	Jun 05
E ETD $20.67	3.19%	Jun 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by